<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Five personal observations of an <z:hpo ids='HP_0011009'>acute</z:hpo> amnestic episode in younger individuals after intake of clioquinol are described together with three observations from the medical literature </plain></SENT>
<SENT sid="1" pm="."><plain>In five of these cases the episode began after an unusually large dose, in three after a therapeutic one with a latency of about 24 hours </plain></SENT>
<SENT sid="2" pm="."><plain>The clinical aspect closely resembled classical <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo> but the episode after clioquinol lasted longer (24 hours to three days) and a more or less extensive <z:e sem="disease" ids="C0002624" disease_type="Mental or Behavioral Dysfunction" abbrv="">retrograde amnesia</z:e> persisted permanently </plain></SENT>
<SENT sid="3" pm="."><plain>In one patient after three tablets of Mexase a clioquinol concentration of 12 microgram/ml in plasma was found 24 hours after the specified dose, which is an unexpectedly high concentration compared to those reported as late as 24 hours after a single equal dose of Mexase or any other clioquinol-containing preparation </plain></SENT>
<SENT sid="4" pm="."><plain>Another patient had a brief relapse two years after the first episode, after a single therapeutic dose of another clioquinol preparation </plain></SENT>
</text></document>